Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mancuso

Showing results (421-430 of 467) with videos related to

Pageof 47
Sort By:
British Journal of Cancer|November 26, 1999
p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancerG Ferrandina, A Fagotti, M G Salerno, et al.
British Journal of Cancer|December 1, 1990
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cellsG Scambia, F O Ranelletti, P B Panici, et al.
Bone Marrow Transplantation|May 1, 1991
Autologous bone marrow processing for autotransplantation using an automated cell processor and a semiautomated procedureL Pierelli, G Menichella, R Serafini, et al.
Anti-Cancer Drug Design|September 1, 1995
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationshipsR De Vincenzo, G Scambia, P Benedetti Panici, et al.
Experimental Hematology|May 17, 2000
The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesisA Battaglia, A Fattorossi, L Pierelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinomaS Fiumicino, A Ercoli, G Ferrandina, et al.
British Journal of Cancer|January 1, 1997
Prognostic significance of ras/p21 alterations in human ovarian cancerG Scambia, V Masciullo, P Benedetti Panici, et al.
British Journal of Haematology|April 12, 2000
CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/- precursorsL Pierelli, G Scambia, G Bonanno, et al.
International Journal of Cancer|September 25, 1997
Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cellsM Distefano, G Scambia, C Ferlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patientsG Ferrandina, L Lauriola, G F Zannoni, et al.
Pageof 47

Showing results (421-430 of 467) with videos related to

Sort By:
Pageof 47
British Journal of Cancer|November 26, 1999
p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancerG Ferrandina, A Fagotti, M G Salerno, et al.
British Journal of Cancer|December 1, 1990
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cellsG Scambia, F O Ranelletti, P B Panici, et al.
Bone Marrow Transplantation|May 1, 1991
Autologous bone marrow processing for autotransplantation using an automated cell processor and a semiautomated procedureL Pierelli, G Menichella, R Serafini, et al.
Anti-Cancer Drug Design|September 1, 1995
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationshipsR De Vincenzo, G Scambia, P Benedetti Panici, et al.
Experimental Hematology|May 17, 2000
The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesisA Battaglia, A Fattorossi, L Pierelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinomaS Fiumicino, A Ercoli, G Ferrandina, et al.
British Journal of Cancer|January 1, 1997
Prognostic significance of ras/p21 alterations in human ovarian cancerG Scambia, V Masciullo, P Benedetti Panici, et al.
British Journal of Haematology|April 12, 2000
CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/- precursorsL Pierelli, G Scambia, G Bonanno, et al.
International Journal of Cancer|September 25, 1997
Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cellsM Distefano, G Scambia, C Ferlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patientsG Ferrandina, L Lauriola, G F Zannoni, et al.
Pageof 47